Medroxyprogesterone acetate-d3

• CAT Number: S000809
• Molecular Formula: C24H31D3O4
• Molecular Weight: 389.54
• Purity: ≥95%
• Target: Immunology/Inflammation
• IUPAC Name: [(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] 2,2,2-trideuterioacetate
• InChI: InChI=1S/C24H34O4/c1-14-12-18-19(22(4)9-6-17(27)13-21(14)22)7-10-23(5)20(18)8-11-24(23,15(2)25)28-16(3)26/h13-14,18-20H,6-12H2,1-5H3/t14-,18+,19-,20-,22+,23-,24-/m0/s1/i3D3
• InChIKey: PSGAAPLEWMOORI-IWNHKZBNSA-N
• SMILES: [2H]C([2H])([2H])C(=O)O[C@@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C[C@@H](C4=CC(=O)CC[C@]34C)C)C)C(=O)C

Medroxyprogesterone Acetate-d3 is a high-purity deuterated compound vital for advanced pharmaceutical research. This isotopically labeled version of Medroxyprogesterone Acetate contains three deuterium atoms, making it essential for studies on progestin activity, hormone replacement therapy, and contraceptive efficacy. Its stable isotope labeling ensures precise and reliable analytical results, enhancing the accuracy of pharmacokinetic and pharmacodynamic studies. With improved stability and consistency, Medroxyprogesterone Acetate-d3 integrates seamlessly into various experimental protocols, offering a robust and cost-effective solution for high-precision scientific investigations. Ideal for research and development, it supports the advancement of safer and more effective therapeutic agents.